Genenta Science S.p.A. (GNTA)
NASDAQ: GNTA · Real-Time Price · USD
3.750
-0.050 (-1.32%)
Aug 7, 2025, 4:00 PM - Market closed
Genenta Science Market Cap
Genenta Science has a market cap or net worth of $69.50 million as of August 8, 2025. Its market cap has increased by 29.69% in one year.
Market Cap
69.50M
Enterprise Value
56.41M
1-Year Change
29.69%
Ranking
Category
Stock Price
$3.75
Market Cap Chart
Since the IPO on December 15, 2021, Genenta Science's market cap has decreased from $208.76M to $69.50M, a decrease of -66.71%. That is a compound annual growth rate of -26.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2025 | 69.50M | -12.64% |
| Dec 31, 2024 | 79.56M | -11.77% |
| Dec 29, 2023 | 90.17M | -10.00% |
| Dec 30, 2022 | 100.19M | -49.56% |
| Dec 31, 2021 | 198.63M | -4.85% |
| Dec 15, 2021 | 208.76M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 665.56B |
| Johnson & Johnson | 413.05B |
| AbbVie | 344.85B |
| AstraZeneca | 231.42B |
| Novartis AG | 228.98B |
| Abbott Laboratories | 228.03B |
| UnitedHealth Group | 225.29B |
| Novo Nordisk | 200.63B |